US 9301509
Genetically modified mice and engraftment
granted A61KA61K49/00
Quick answer
US patent 9301509 (Genetically modified mice and engraftment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K49/00